NOVT Novanta Inc.

114.88USD-2.55%Mkt Cap: 4.34B USDP/E: 87.03

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internatio…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap4.34B USD
Enterprise Value5.20B USD
Revenue (TTM)1.09B USD
Gross Profit435.28M USD
Net Income (TTM)53.83M USD
Revenue/Share26.78 USD
Last Price114.88 USD
Fiscal Year EndDec 2025
MR QuarterOct 2026
Employees3.0K
CountryUS
SectorTechnology
IndustryScientific & Technical Instruments
ISIN—
Valuation
P/E (Trailing)87.03
P/E (Forward)26.90
PEG—
EV/EBITDA25.87
EV/Revenue4.79
P/S4.00
P/B2.67
EPS (TTM)1.32 USD
EPS (Forward)4.27 USD
52W Range
98.2721% of range176.19
52W High176.19 USD
52W Low98.27 USD
Profitability
Gross Margin44.39%
Oper. Margin11.76%
EBITDA Margin18.51%
Profit Margin5.49%
ROE4.10%
ROA2.98%
ROIC7.30%
ROCE7.32%
Growth
Revenue Growth23.10%
Earnings Growth-84.00%
Cash Flow & Leverage
Operating CF64.06M USD
CapEx (TTM)15.63M USD
FCF Margin33.12%
FCF Yield8.28%
Net Debt744.92M USD
Net Debt/EBITDA3.70
Net Debt/FCF2.07
Balance Sheet
Debt/Equity0.23
Current Ratio1.18
Quick Ratio0.69
Book Value/Sh42.95 USD
Cash/Share3.94 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:3
Split DateDec 29, 2010
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)185.00 USD
Upside (mean)+61.0%
Target Range175.00 USD – 195.00 USD
175.00+61.0% to mean195.00
# Analysts2
Ownership
Shares Out.37.82M
Float37.54M
Insiders0.71%
Institutions122.14%
Short Interest
Short Ratio12.3d
Short % Float15.95%
Short % Out.13.88%
Shares Short5.25M
Short (prev mo.)5.14M
Technical
SMA 50139.61 (-17.7%)
SMA 200142.02 (-19.1%)
Beta1.70
S&P 52W Chg12.08%
Avg Vol (30d)529.98K
Avg Vol (10d)703.56K
Technical Indicators
RSI (14)35.5
MACD-7.3018
MACD Signal-4.9829
MACD Hist.-2.3189
BB Upper162.19 USD
BB Middle133.97 USD
BB Lower105.76 USD
BB Width42.12%
ATR (14)7.726 USD
Vol Ratio (20d)0.79x

About Novanta (NASDAQ: NOVT)

›

Novanta (NASDAQ: NOVT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 3,000 employees.

The shares were at 114.88 USD on 19 November 2026, up 7.1% over 52 weeks. Its 52-week range is 98.27 USD to 176.19 USD: the price is 34.8% below the high and 16.9% above the low.

At a market capitalisation of 4.34B USD, it trades at 87.0 times trailing earnings and 26.9 times forward earnings. The median trailing P/E of its 19 largest Scientific & Technical Instruments peers is 30.2, a premium of 188% for NOVT.

Novanta reports return on equity of 4.1%, an operating margin of 11.8% and revenue up 23.1% year over year.

Its debt exceeds its cash by 744.92M USD, a debt-to-equity ratio of 0.23. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 185.00 USD is 61.0% above the current price. The next earnings report is expected on 23 February 2027.